Bridget Wright, MD
Rheumatology · Vidalia, GANPI 1861506768
Payments from drug & device makers
Across 1,142 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- AbbVie$3K
- UCB, Inc.$2K
- Novartis$1K
- Johnson & Johnson$1K
- Aurinia Pharma U.S., Inc.$1K
- plus $6K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 240 | $3,701 |
| AbbVie | 177 | $3,200 |
| UCB, Inc. | 172 | $2,265 |
| Novartis | 102 | $1,475 |
| Johnson & Johnson(2 entities) | 76 | $1,417 |
| Aurinia Pharma U.S., Inc. | 56 | $1,064 |
| Pfizer | 56 | $941 |
| GSK | 41 | $765 |
| AstraZeneca(2 entities) | 35 | $573 |
| Sanofi | 26 | $439 |
| Lilly USA, LLC | 24 | $398 |
| Genentech USA, Inc. | 19 | $259 |
| Boehringer Ingelheim | 11 | $202 |
| E.r. Squibb & Sons, L.L.C. | 11 | $190 |
| Mallinckrodt Hospital Products Inc. | 7 | $185 |
| Bristol Myers Squibb | 9 | $181 |
| Antares Pharma, Inc. | 10 | $171 |
| Hikma Pharmaceuticals USA | 10 | $159 |
| Medexus Pharma, Inc. | 8 | $145 |
| Sanofi-aventis U.S. LLC | 3 | $124 |
| Organon | 8 | $114 |
| Radius Health, Inc. | 5 | $85 |
| Mallinckrodt Enterprises LLC | 6 | $81 |
| Actelion Pharmaceuticals US, Inc. | 5 | $64 |
| ANI Pharmaceuticals, Inc. | 3 | $59 |
| CSL Behring | 2 | $54 |
| Sandoz | 2 | $54 |
| Fresenius Kabi USA, LLC | 3 | $53 |
| Scilex Pharmaceuticals Inc. | 2 | $48 |
| Zyla Life Sciences, Inc. | 3 | $40 |
| Octapharma USA, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Merck | 2 | $25 |
| Ultragenyx Pharmaceutical Inc. | 2 | $25 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $16 |
| Roche Diagnostics Corporation | 1 | $14 |
How this compares
$18,672 in reported general payments places this provider in the 75th percentile of 177 rheumatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Vidalia
- Theresa Lawrence FordLawrenceville$2.9M
- Wambui MachuaAtlanta$1.8M
- Brent FlickingerGainesville$1.6M
- James MossellTifton$1.6M
- Roel QuerubinMarietta$1.5M
- Arezou KhosroshahiAtlanta$1.5M
- Sung LimAtlanta$1.3M
- Gary MyersonAtlanta$1.3M
- Jefrey LiebermanDecatur$761K
- Marta BognarGainesville$719K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.